يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Belen San Antonio"', وقت الاستعلام: 1.07s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: Institut Català de la Salut, [Johnston SRD] Royal Marsden NHS Foundation Trust, London, United Kingdom. [Harbeck N] Department of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany. [Hegg R] Clinica Pesquisas e Centro São Paulo, São Paulo, Brazil. [Toi M] Kyoto University Hospital, Kyoto, Japan. [Martin M] Hospital General Universitario Gregorio Marañon, Universidad Complutense, Ciberonc, GEICAM, Madrid, Spain. [Shao ZM] Fudan University Shanghai Cancer Center, Shanghai, China. [Cortés J] IOB Institute of Oncology, Quiron Group, Madrid, Barcelona. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Journal of Clinical Oncology

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::antineoplásicos hormonales [COMPUESTOS QUÍMICOS Y DROGAS], Receptor, ErbB-2, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], medicine.medical_treatment, Medicaments antineoplàstics - Ús terapèutic, Aminopyridines, law.invention, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Hormonal [CHEMICALS AND DRUGS], chemistry.chemical_compound, 0302 clinical medicine, Mama - Càncer, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Breast, Young adult, Abemaciclib, Early breast cancer, Aged, 80 and over, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Middle Aged, Therapeutics::Combined Modality Therapy::Neoadjuvant Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Receptors, Estrogen, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Female, Receptors, Progesterone, Adjuvant, Adult, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Breast Neoplasms, Disease-Free Survival, monarchE Committee Members and Investigators, 03 medical and health sciences, Young Adult, Internal medicine, RAPID COMMUNICATIONS, Breast Cancer, medicine, Humans, Protein Kinase Inhibitors, Aged, Chemotherapy, business.industry, Endocrine therapy, Clinical trial, 030104 developmental biology, chemistry, terapéutica::tratamiento combinado::tratamiento neoadyuvante [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Benzimidazoles, Neoplasm Recurrence, Local, business

    وصف الملف: application/pdf; Print-Electronic

  6. 6
  7. 7
  8. 8

    المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

    المصدر: Govindan, R, Senan, S, Dickgreber, N, Provencio, M, Wu, Y-L, Syrigos, K, Parente, B, Wilson, M, Ziemiecki, R, Chouaki, N, Hossain, A, San Antonio, B, Winfree, K & Vokes, E E 2019, ' Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer ', Current Medical Research and Opinion, vol. 35, no. 10, pp. 1761-1767 . https://doi.org/10.1080/03007995.2019.1623185
    Current Medical Research and Opinion, 35(10), 1761-1767. Taylor and Francis Ltd.

  9. 9
  10. 10